Crestor, manufactured by AstraZeneca Pharmaceuticals, was approved by the Food & Drug Administration (FDA) in August 2003. Marketed as a “super-statin,” Crestor was alleged to lower LDL cholesterol more than other statin drugs. Statins differ in the way they are broken down or expelled by the body. Whereas most statins are metabolized through the liver…